Norman Viner

Dr. Norm Viner is the former Chief of the Clinical Trials Division, Health Canada where he oversaw clinical aspects of Biologic and Genetic Therapies applications. This encompassed clinical trial research proposals for new drug indications involving biologic products, gene therapies, stem cell therapies, radiopharmaceuticals and vaccines, and joint reviews with both therapeutic products and devices. He currently guides iBIONICS on achievable clinical trial design and execution including complying with and navigating the regulatory system. Dr. Viner, a graduate of the University of Ottawa medical school, was in full-time general practice for 18 years and is a hospitalist at the Queensway Carleton Hospital. He conceived a potential smoking cessation therapy including the running of a pilot study involving the design, manufacturing, and use of a prototype pharmaceutical product. Dr. Viner has authored a number of peer-reviewed articles and patents.